Edition:
United States

Profile: Walvax Biotechnology Co Ltd (300142.SZ)

300142.SZ on Shenzhen Stock Exchange

24.61CNY
21 May 2018
Change (% chg)

¥0.41 (+1.69%)
Prev Close
¥24.20
Open
¥24.33
Day's High
¥24.64
Day's Low
¥24.11
Volume
10,081,193
Avg. Vol
15,866,468
52-wk High
¥25.16
52-wk Low
¥11.59

Walvax Biotechnology Co., Ltd. is a China-based company principally engaged in the research, development, production and distribution of vaccines, monoclonal antibodies and blood products. The Company’s main products include haemophilus influenza type b conjugate vaccines, freeze-dried group A,C meningococcal polysaccharide conjugate vaccines, group ACYW135 meningococcal polysaccharide vaccines and group A and C meningococcal polysaccharide vaccines, among others. The Company distributes its products mainly in domestic market.

Company Address

Walvax Biotechnology Co Ltd

19F, Tower A, Building 9
Dingyi Tiancheng, No.99, Keyuan
Hi-Tech Zone
KUNMING   YUN   650106
P: +86871.68312779
F: +86871.68312779

Company Web Links